Pharmaceuticals are the U.S.'s second-largest import category from India, which services 40% of the country’s demand for generics. MNCs are expanding in the Indian market as well. Successful cooperation between the United States and India during the COVID-19 pandemic is a direct result of growing strategic partnership and increasing private sector and people-to-people ties over the years. With India’s expansive vaccine manufacturing capacity and the coronavirus devastating both nations, this Townhall is an opportune engagement for Industry to reconnect along shared values and ethics for a reinvigorated approach to supporting conducive, balanced bilateral policy reforms.

INDIA U.S. TRADE TOWNHALL ‘Strengthening U.S.-India Pharma Cooperation & Vaccine Diplomacy’.